Ada's latest news

Ada Full Gospel hosts their Vacation Bible School next week, from Monday, July 8 through Thursday, July 11 from 6 to 9 p.m. 

Mr. Molecule - he's a scientist and magician

The Ada Public Library has another exciting week planned for its summer reading program.

On Monday at 11 a.m. Mr. Molecule comes to Ada. He’s a scientist and magician  and he will present a program for kids at the First United Methodist.

And, each day this week (July 1-6) that reading program participants check out a “oversized” book, each participant will receive a prize.

The library says that there’s one ticket earned per day. If you aren’t registered for the summer program, there’s still time to sign up.

 

The Icon caught up with Klondike as it checked out the skies for meteors. It turns out that today, (JUNE 30)  is National Meteor Watch Day.  Also known as National Meteor Day, on a cloudless night, people turn their eyes to the heavens in hopes of spotting the glow of a falling star. Daily there are millions of meteors that occur in the Earth’s atmosphere.

Due to liability and insurance issues, facility usage is limited to preapproved activities

Ada schools issues a statement on its Bulldog Facebook concerning the use of its facilities. The announcement follows:

Due to liability and insurance issues, facility usage (such as gyms, weight room, and athletic or other areas) is limited to preapproved activities.

Current student athletes may only use these facilities under the supervision of a current board-approved coach.

Students should never be unsupervised in any building or facility. Keys should only be in the possession of current employees and board approved coaches.

All others who may have a key should turn those in to the central office immediately.

FDA approves new drug that treats breast, stomach and esophageal cancer

Note: this article provided by ONU Healthwise Pharmacy.
The US Food and Drug Administration (FDA) has approved another biosimilar to a drug that treats breast, stomach and esophageal cancer.

This biosimilar is called Kanjinti (trastuzumab-anns). The FDA approved it because it appeared to have no meaningful differences from Herceptin (trastuzumab), which has already been approved.

If a drug is a biosimilar to another drug, that means it is nearly identical to the other drug (called the reference product). According to the FDA's recent approval, Kanjinti is a biosimilar to Herceptin.

By Chris Steffan, RN, ADON
Birchaven Village
Dementia is a general term used to describe various symptoms of cognitive decline including impairment in memory, communication and thinking, which is caused by damage to cells in the brain. The symptoms do not appear suddenly but build over time and become more noticeable. Damage can occur for many reasons including increased proteins inside and outside of brain cells, lack of oxygen to the brain, stroke, genetics, medication side effects, depression, alcohol use, and thyroid and vitamin deficiencies.

Symptoms of dementia could be:

Pages